Abstract: Provided is a multi-target compound with anticoagulation and platelet GPIIb/IIIa receptor antagonism. The formula of the multi-target compound is as follows: A-L-B-L?-C. A and B are binding sites with a thrombin, C is a binding site with a platelet GPIIb/IIIa receptor, L is a first linking group, and L? is a second linking group. Also provided are a preparation method for the compound and use of the compound. The compound has the effects on inhibiting human thrombin activity and a platelet GPIIb/IIIa receptor in vitro, and has the effects on antiplatelet aggregation in vitro/in vivo, and anticoagulation and antithrombosis in vivo.

Abstract: An automatic activator coating device for wire and arc additive manufacture includes a base, a mechanical arm is arranged on the upper side of the base, a clamping mechanism is arranged at the lower end of the mechanical arm, a container bottle is clamped on the clamping mechanism, one end of the container bottle is communicated with a sprayer, one end of the sprayer is communicated with an atomizing nozzle, the container bottle is communicated with the gas bottle, and a gas pressure regulating valve is arranged on the gas bottle; and a piston partition is arranged in the sprayer, the container bottle is communicated with an activator converging cavity in one end of the sprayer, a piston rod and a resetting mechanism are arranged in a mounting cavity in the other end of the sprayer, an open hole is formed in the inner surface of the sprayer

Abstract: Disclosed is a combined process for preparing zirconium oxide, methyl chlorosilane and/or polycrystalline silicon and a combined system comprising: preparing zirconium oxide by using zircon sand, carbon, chlorine gas, silicon, and hydrogen chloride as raw materials, the products separated during preparing zirconium oxide include gas phase products and liquid phase products, methyl chlorosilane is prepared from the gas phase separated during preparing zirconium oxide, and polycrystalline silicon is prepared by using the liquid phase products as raw materials.

Abstract: The invention relates to a ternary blend having a core/shell structure including (1) PA as a matrix, and (2) a core/shell particle. The ternary blend includes 60-80 wt % of PA and 20-40% of core/shell particle based on the total weight of the ternary blend. The shell is EPDM-g-MA, and the core is PP or PC.

Abstract: In one embodiment, a method includes generating an outputted sequence of warped images from a captured sequence of images. Using this captured sequence of images, a computing system may determine one or more three-dimensional locations of object features and a corresponding camera position for each image in the captured sequence of images. Utilizing the camera positions for each image, the computing system may determine a view path representing the perspective of a virtual camera. The computing system may identify one or more virtual camera positions for the virtual camera located on the view path, and subsequently warp one or more images from the sequence of captured images to represent the perspective of the virtual camera at each of the respective virtual camera positions. This results in a sequence of warped images that may be outputted for viewing and interaction on a client device.

Abstract: Provided are a compound for treating metabolic diseases having the structure as shown in formula (I) or formula (II), or a racemate, stereoisomer, geometric isomer, tautomer, solvate, hydrate, metabolite, pharmaceutically acceptable salt or prodrug thereof. The compound is an activator of FXR and/or a TGR5 receptor, and thus has the activity of activating FXR and/or a TGR5 receptor, and can be used in the preparation of drugs for treating chronic liver diseases, metabolic diseases or portal hypertension.

Abstract: The invention relates to a ternary blend having a core/shell structure including (1) PA as a matrix, and (2) a core/shell particle. The ternary blend includes 60-80 wt % of PA and 20-40% of core/shell particle based on the total weight of the ternary blend. The shell is EPDM-g-MA, and the core is PP or PC.

Abstract: Provided is a method of damping mechanical oscillations of plural wind turbines of a wind park commonly supplying electric energy to a grid, the method including: determining, for each of the plural wind turbines, a damping control signal for counteracting an oscillation of the respective wind turbine; supplying at least a subset of or a subset of modified versions of the damping control signals to respective wind turbines such that a sum of the supplied damping control signals is lower than a threshold.

Abstract: Methods and kits are provided for diagnosing, monitoring, or predicting preeclaimpsia in a pregnant woman, trisomy 18 and trisomy 21 in a fetus, as well as for detecting pregnancy in a woman, by quantitatively measuring in the maternal blood the amount of one or more RNA species derived from a set of genetic loci and comparing the amount of the RNA species with a standard control.

Abstract: A method for measuring electric power includes: mounting a sensing device on a wire between a capturing device and an electronic goods, wherein the capturing device is used for capturing a total power consumption value of the wire; measuring a relative electricity value of the wire using the sensing device; establishing a solution model based on the relative electricity value to output a loop power consumption result of the wire; determining whether the solution model satisfies a predefined condition, wherein the predefined condition includes the loop power consumption result of the wire being close to the power consumption value captured by the capturing device; and when the solution model satisfies the condition, outputting an absolute electricity value of the wire.

Abstract: Techniques that enable a third party to author and add functionality to a target application. A third party may create or author a script that encodes the functionality to be added to the target application. The script may then be provided to and executed by the target application, where execution of the script causes the functionality to be added to the target application. In certain embodiments, the added functionality may be in the form of effects that are output via the target application when the script is executed by the target application. The effects may include audio-visual effects that are displayed or output by the target application and may also include displaying data provided by a third party.

Abstract: Provided are a compound for treating metabolic diseases having the structure as shown in formula (I) or formula (II), or a racemate, stereoisomer, geometric isomer, tautomer, solvate, hydrate, metabolite, pharmaceutically acceptable salt or prodrug thereof. The compound is an activator of FXR and/or a TGR5 receptor, and thus has the activity of activating FXR and/or a TGR5 receptor, and can be used in the preparation of drugs for treating chronic liver diseases, metabolic diseases or portal hypertension.

Abstract: A sensing device includes a housing positioned on an outer surface of a wire and a circuit board received in the housing. The circuit board has a sensing area for sensing the wire, such that the measurements obtained by the circuit board are relative values. Therefore, the circuit design of the circuit board can be simplified, and the size of the sensing device can be reduced.

Abstract: Methods are provided for diagnosing pregnancy-associated disorders, determining allelic ratios, determining maternal or fetal contributions to circulating transcripts, and/or identifying maternal or fetal markers using a sample from a pregnant female subject. Also provided is use of a gene for diagnosing a pregnancy-associated disorder in a pregnant female subject.

Abstract: The present invention provides a method and an apparatus for fracturing polycrystalline silicon, and the method includes steps of placing the polycrystalline silicon in a water tank containing water; applying an instant high voltage to the water tank so that high-voltage discharge occurs in the water of the water tank to fracture the polycrystalline silicon. The method and apparatus have advantages of simple process, uniform fragments and no metal contamination.

Abstract: A sensing device includes a housing positioned on an outer surface of a wire and a circuit board received in the housing. The circuit board has a sensing area for sensing the wire, such that the measurements obtained by the circuit board are relative values. Therefore, the circuit design of the circuit board can be simplified, and the size of the sensing device can be reduced.

Abstract: A method for measuring electric power includes: mounting a sensing device on a wire between a capturing device and an electronic goods, wherein the capturing device is used for capturing a total power consumption value of the wire; measuring a relative electricity value of the wire using the sensing device; establishing a solution model based on the relative electricity value to output a loop power consumption result of the wire; determining whether the solution model satisfies a predefined condition, wherein the predefined condition includes the loop power consumption result of the wire being close to the power consumption value captured by the capturing device; and when the solution model satisfies the condition, outputting an absolute electricity value of the wire.

Abstract: An operating button includes a light source, a push rod with a diverging lens, and an operating head with a condensing lens. The optical center of the diverging lens, the optical center of the condensing lens and the light source are in the same line such that light rays generated by the light source pass through the diverging lens and the converging lens before exiting the operating head as parallel light.

Abstract: Methods are provided for diagnosing pregnancy-associated disorders, determining allelic ratios, determining maternal or fetal contributions to circulating transcripts, and/or identifying maternal or fetal markers using a sample from a pregnant female subject. Also provided is use of a gene for diagnosing a pregnancy-associated disorder in a pregnant female subject.